COMBINED INFLUENZA VACCINES FOR SEASONAL AND PANDEMIC PROTECTION

Influenza virus immunizing epitope

Compositions Comprising Salmonella Porins and Uses Thereof as Adjuvants and Vaccines

Multimeric multiepitope influenza vaccines

ADJUVANTED INFLUENZA VACCINES INCLUDING CYTOKINE-INDUCING AGENTS

DNA PRIME/ACTIVATED VACCINE BOOST IMMUNIZATION TO INFLUENZA VIRUS

INFLUENZA VACCINES

CELL-BASED SYSTEMS FOR PRODUCING INFLUENZA VACCINES

Deletion mutants of flagellin and methods of use

NOVEL USE

Compositions that Include Hemagglutinin, Methods of Making and Methods of Use Thereof

Microneedle device, and method for enhancing the efficacy of influenza vaccine by using microneedle device

Influenza B Vaccines

Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds

MALVA MOSAIC VIRUS AND VIRUS-LIKE PARTICLES AND USES THEREOF

INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS

Methods and compositions for expressing negative-sense viral RNA in canine cells

Baculovirus expression vector and method therewith for generating immunogenicity in a host

VACCINES INCLUDING ANTIGEN FROM FOUR STRAINS OF INFLUENZA VIRUS

Influenza Vaccines Containing Hemagglutinin and Matrix Proteins

CHIMERIC VARICELLA ZOSTER VIRUS VIRUS-LIKE PARTICLES

System for the heterologous expression of a viral protein in a ciliate host cell

Influenza hemagglutinin and neuraminidase variants

Modified influenza virus

Influenza B viruses having alterations in the hemaglutinin polypeptide

RECOMBINANT INFLUENZA VIRUS-LIKE PARTICLES (VLPS) PRODUCED IN TRANSGENIC PLANTS EXPRESSING HEMAGGLUTININ

Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity

Influenza virus vaccines and uses thereof

Vaccines comprising an immunostimulatory peptide and an immunostimulatory oligodeoxynucleic acid molecule

Method of eliciting an immune response against pandemic influenza virus

Compositions and vaccines against influenza A and influenza B infections

Alpha thymosin peptides as vaccine enhancers

Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds

Formulation of Sugar Solutions for Continuous Ultracentrifugation for Virus Purification

Two-Step Temperature Profile for the Propagation of Viruses

NOVEL METHODS AND INTERFERON DEFICIENT SUBSTRATES FOR THE PROPAGATION OF VIRUSES

NOVEL VACCINE COMPOSITION

Process for manufacturing vaccines

METHODS AND COMPOSITIONS FOR EXPRESSING NEGATIVE-SENSE VIRAL RNA IN CANINE CELLS

Oil-in-water emulsion influenza vaccine

Avian influenza chimeric VLPS

LOW-ADDITIVE INFLUENZA VACCINES

Vaccine Comprising an Oil in Water Emulsion Adjuvant

ADMINISTRATION ROUTES FOR PRIMING/BOOSTING WITH INFLUENZA VACCINES

ATTENUATED NEGATIVE STRAND VIRUSES WITH ALTERED INTERFERON ANTAGONIST ACTIVITY FOR USE AS VACCINES AND PHARMACEUTICALS

INTRADERMAL INFLUENZA VACCINE

Methods for cultivating cells, propagating and purifying viruses

VACCINE COMPOSITIONS OF M2e, HA0 AND BM2 MULTIPLE ANTIGENIC PEPTIDES

Storage of Influenza Vaccines Without Refrigeration

Peptide sequences and compositions

Cell-based systems for producing influenza vaccines

MAKING INFLUENZA VIRUS VACCINES WITHOUT USING EGGS

Production of vaccines

Neuraminidase-deficient live influenza vaccines

Refrigerator-temperature stable influenza vaccine compositions

MUCOSAL IMMUNOGENIC SUBSTANCES COMPRISING A POLYINOSINIC ACID - POLYCYTIDILIC ACID BASED ADJUVANT

Nanoemulsion influenza vaccine

INFLUENZA VACCINES WITH REDUCED AMOUNT OF EMULSION ADJUVANT

Influenza vaccines including combinations of particulate adjuvants and immunopotentiators

Influenza vaccine

Cell-derived viral vaccines with low levels of residual cell DNA

Inactivated influenza virus compositions

Multi plasmid system for the production of influenza virus

INFLUENZA NUCLEIC ACIDS, POLYPEPTIDES, AND USES THEREOF

Vaccine Compositions Comprising Virosomes and a Saponin Adjuvant

Enhancement of an immune response by administration of a cationic lipid-DNA complex (CLDC)

INFLUENZA VACCINE

Immunogenic composition

Methods of Producing Influenza Vaccine Compositions

Process for stabilizing an adjuvant containing vaccine composition

Adjuvanted influenza vaccines for pediatric use

Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture

EMULSIONS WITH FREE AQUEOUS-PHASE SURFACTANT FOR ADJUVANTING SPLIT INFLUENZA VACCINES

Methods of producing influenza vaccine compositions

Multi plasmid system for the production of influenza virus

Methods for the propagation of modified influenza viruses in embryonated eggs

Influenza Hemagglutinin And Neuraminidase Variants

Method for producing temperature sensitive influenza A viruses

Influenza Hemagglutinin And Neuraminidase Variants

Novel vaccine

Influenza vaccine

Immunogenic composition

Peptide-Based Influenza Vaccine Formulation

COMPOSITION

Decreasing potential iatrogenic risks associated with influenza vaccines

Dry Formulation for Transcutaneous Immunization

Method for producing viral vaccines

Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals

CHANGING TH1/TH2 BALANCE IN SPLIT INFLUENZA VACCINES WITH ADJUVANTS

Immunogenic composition

Novel use

Polyvalent influenza virus-like particle (VLP) compositions

Influenza Vaccination

Attenuated influenza virus and a live vaccine comprising the same

Two-step temperature profile for the propagation of viruses

Vaccine Compositions Comprising a Saponin Adjuvant

Formulation of sugar solutions for continuous ultracentrifugation for virus purification

Lyophilization of virosomes

PROTEOSOME INFLUENZA VACCINE

Process for the Production of an Influenza Vaccine

Preservation of bioactive materials by freeze dried foam

Vaccine

Immunogenic composition

Immunogenic composition

NOVEL VACCINE COMPOSITION

Use Of An Influenza Virus, An Oil-In-Water Emulsion Adjuvant, To Induce Cd4 T-Cell And/Or Improved B-Memory Cell Response

Novel Composition

Preservation of bioactive materials by freeze dried foam

Production of viruses, viral isolates and vaccines

Intranasal or inhalational administration of virosomes

Method of vaccinating subjects receiving immune modulating therapy

Vaccine formulations for intradermal delivery comprising adjuvants and antigenic agents

Compositions that include hemagglutinin

Non-live trivalent influenza vaccine for one-dose intradermal delivery

Intranasal or inhalational administration of virosomes

Compositions that include hemagglutinin, methods of making and methods of use thereof

Novel Vaccine Containing Adjuvant Capable Of Inducing Mucosal Immunity

Thermoreversible oil-in-water emulsion

Cold-adapted (CA) reassortant influenza virus

Mucosal immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant

Methods of Producing Influenza Vaccine Compositions

Influenza vaccine

Processes for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process

Methods and compositions for expressing negative-sense viral RNA in canine cells

Systems and methods for identifying Replikin Scaffolds and uses of said Replikin Scaffolds

Immuno-adjuvant emulsion

Method and device for transdermal immunization

Methods and compositions for expressing negative-sense viral RNA in canine cells

Vaccines

Influenza hemagglutinin and neuraminidase variants

Influenza nucleic acids, polypeptides, and uses thereof

Sphingoid polyalkylamine conjugates for Hepatitis B virus vaccination

Vaccine formulations for intradermal delivery comprising adjuvants and antigenic agents

Recombinant influenza vectors with tandem transcription units

Methods of producing influenza vaccine compositions

Inactivated influenza virus vaccine for nasal or oral application

Compositions with enhanced immunogenicity

Refrigerator-temperature stable influenza vaccine compositions

Production of vaccines

Novel vaccine

Production of vaccines

Method for preparation of vesicles loaded with biological material and different uses thereof

Transcutaneous immunization without heterologous adjuvant

Multi plasmid system for the production of influenza virus

Molecules enhancing dermal delivery of influenza vaccines

Apparatus and method for transdermal delivery of influenza vaccine

Compositions comprising antigen-complexes, method of making same as well as methods of using the antigen-complexes for vaccination

Intranasal influenza virus vaccine

Inactivated influenza virus vaccine for nasal or oral application

Multi plasmid system for the production of influenza virus

Production of viruses viral isolates and vaccines

Molecules enhancing dermal delivery of influenza vaccines

Methods and interferon deficient substrates for the propagation of viruses

Influenza hemagglutinin and neuraminidase variants

Stabilized hemagglutinin (HA) trimers as influenza vaccine antigens

Transient expression of biologic materials